Lord Kelvin Adam Smith Research Fellow in the Social Sciences, School of Social and Political Sciences, University of Glasgow, Adam Smith Bdg, Bute Gardens, G12 8RT, UK,
J Bioeth Inq. 2013 Dec;10(4):505-14. doi: 10.1007/s11673-013-9476-1. Epub 2013 Oct 4.
In this paper I revisit previous critiques that I have made of much, though by no means all, bioethical discourse. These pertain to faithfulness to dualistic ontology, a taken-for-granted normative anthropocentrism, and the exclusion of a consideration of how political economy shapes the conditions for bioethical discourse (Twine Medicine, Health Care and Philosophy 8(3):285-295, 2005; International Journal of Sociology of Agriculture and Food 16(3):1-18, 2007, 2010). Part of my argument around bioethical dualist ontology is to critique the assumption of a division between the "medical" (human) and "agricultural" (nonhuman) and to show various ways in which they are interrelated. I deepen this analysis with a focus on transnational pharmaceutical companies, with specific attention to their role in enhancing agricultural production through animal drug administration. I employ the topical case of antibiotics in order to speak to current debates in not only the interdisciplinary field of bioethics but also that of animal studies. More generally, the animal-industrial complex (Twine Journal for Critical Animal Studies 10(1):12-39, 2012) is underlined as a highly relevant bioethical object that deserves more conceptual and empirical attention.
在本文中，我重新审视了我之前对许多（尽管不是全部）生物伦理话语的批评。这些批评涉及到对二元论本体论的忠实、理所当然的规范人类中心主义，以及对政治经济学如何塑造生物伦理话语条件的考虑的排除（Twine Medicine，Health Care and Philosophy 8(3):285-295, 2005; International Journal of Sociology of Agriculture and Food 16(3):1-18, 2007, 2010）。我对生物伦理二元论本体论的部分论点是批评将“医学”（人类）和“农业”（非人类）之间的划分的假设，并展示它们相互关联的各种方式。我通过关注跨国制药公司来深化这一分析，特别关注它们通过动物药物管理来促进农业生产的作用。我利用抗生素这一热门案例，不仅涉及生物伦理学的跨学科领域，也涉及动物研究领域的当前辩论。更广泛地说，动物工业综合体（Twine Journal for Critical Animal Studies 10(1):12-39, 2012）是一个高度相关的生物伦理对象，值得更多的概念和经验关注。
